-+ 0.00%
-+ 0.00%
-+ 0.00%

Helus Pharma Appoints Michael Halstead CEO, Effective Immediately

Benzinga·08/03/2026 11:44:04
Listen to the news

Helus Pharma (NASDAQ:HELP) (Cboe CA: HELP) (the "Company" or "Helus Pharma"), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists ("NSAs"), today announced the appointment of Michael Halstead as Chief Executive Officer, effective immediately.